Pharma and Biotech Consulting
Total Trials
18
As Lead Sponsor
0
As Collaborator
Total Enrollment
58,726
NCT00734474
A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
Phase: Phase 2/3
Role: Collaborator
Start: Aug 31, 2008
Completion: Jul 31, 2012
NCT02735707
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Phase: Phase 3
Start: Apr 11, 2016
Completion: Feb 29, 2028
NCT03260920
Intranasal Oxytocin for Frontotemporal Dementia
Phase: Phase 2
Start: Jan 31, 2018
Completion: Dec 31, 2024
NCT03930264
Bioequivalence of Azathioprine Suspension 10 mg/mL (Jayempi) Versus Azathioprine Tablet 50mg (Imurek®)
Phase: Phase 1
Start: Apr 11, 2019
Completion: May 31, 2019
NCT03861767
REMAP Trial for Optimizing Surgical Outcomes at UPMC
Start: Apr 15, 2019
Completion: Sep 23, 2022
NCT03643939
High-Flow Nasal Oxygen Cannula Compared to Non-Invasive Ventilation in Adult Patients With AcuTE Respiratory Failure
Phase: N/A
Start: Nov 1, 2019
Completion: Feb 28, 2024
NCT05018221
Better Evidence and Translation for Calciphylaxis
Start: Aug 26, 2021
Completion: Dec 31, 2029
NCT05137119
Staphylococcus Aureus Network Adaptive Platform Trial
Phase: Phase 4
Start: Feb 16, 2022
Completion: Dec 1, 2028
NCT04577859
Esophageal Protection Study: A Multicenter Study
Start: Mar 10, 2022
Completion: May 31, 2026
NCT04606264
Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data
Start: May 15, 2023
Completion: Mar 21, 2025
NCT05422612
Department of Defense PTSD Adaptive Platform Trial - Master Protocol
Start: Nov 2, 2023
Completion: Sep 30, 2026
NCT05948540
Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant
NCT05948553
Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine
NCT06352632
ACT-GLOBAL Adaptive Platform Trial for Stroke
Start: Sep 26, 2024
Completion: Sep 30, 2034
NCT06289985
StrokeNet Thrombectomy Endovascular Platform
Start: Jan 31, 2025
Completion: Jan 31, 2030
NCT06526533
RECOMMEND Platform Trial
Start: Sep 30, 2025
Completion: Jun 30, 2029
NCT05948579
Department of Defense PTSD Adaptive Platform Trial - Intervention B - Vilazodone
Start: Nov 30, 2025
NCT06816433
Department of Defense PTSD Adaptive Platform Trial - Intervention D - SLS-002
Loading map...